Sedana Medical AB (publ)
Climate Impact & Sustainability Data (2022, 2023, 2024)
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Sustainability
- Human Rights
- Responsible Procurement
- Environmental Impact
Environmental Achievements
- Continued efforts to minimize plastic use in packaging
- Increased reflection efficiency of Sedaconda ACD
- Increased capture efficiency and potential recycling of anesthetic gas
- Minimizing air freight and using sea freight for at least 90% of incoming freight volumes
Social Achievements
- Developed an anti-corruption policy and updated the code of conduct
- Introduced a mentorship program for new managers
- Established a legal function and appointed a chief legal officer
- Developed new policies and procedures (anti-corruption, corporate governance, HR)
- Launched 'I Suggest' tool for employee suggestions
- Introduced 'Board Member for a Day' initiative
Governance Achievements
- Updated Code of Conduct
- Developed an anti-corruption policy
- Established a legal function and appointed a chief legal officer
- Developed a whistleblower policy and implemented a whistleblower system
Climate Goals & Targets
Long-term Goals:
- Make inhaled sedation a global standard therapy for mechanically ventilated patients in intensive care
Medium-term Goals:
- Achieve sales in excess of SEK 500 million in Europe by 2025
Short-term Goals:
- Not disclosed
Environmental Challenges
- Reduced sales due to fewer ICU patients and hospital staff shortages post-Covid-19 pandemic
- War in Ukraine impacting supply of AMG-06 gas monitors
- Risks related to regulatory environment for medical devices and pharmaceutical products
- Risks related to product classification system or market access process
- Risks related to implementation and outcomes of clinical studies
- Risks related to competition
- Risks related to third-party agreements
- Risks related to market acceptance
- Risks related to macroeconomic factors
- Dependence on sales and development of a small number of devices
- Risks related to key individuals and qualified personnel
- Risks related to intellectual property rights
- Risks related to fluctuating foreign-exchange rates
- Risks related to current and additional financing
- Risks related to tax demands and changes in tax regulations
- Risks related to accumulated tax losses
Mitigation Strategies
- Halted purchases of AMG-06 gas monitors from Russia and sought alternative suppliers
- Developed an anti-corruption policy and updated the code of conduct
- Established a legal function and appointed a chief legal officer
- Developed new policies and procedures (anti-corruption, corporate governance, HR)
- Implemented a whistleblower system
- Focusing on implementing main priorities: sales growth, cost-effectiveness, and completion of US studies
- Securing medical evidence demonstrating inhaled sedation benefits
- Continuous dialogue with suppliers to ensure compliance with Code of Conduct
- Proactive cooperation with key stakeholders to minimize environmental impact
Supply Chain Management
Supplier Audits: Ongoing dialogue and regular review of suppliers
Responsible Procurement
- Inclusion of clauses in supplier agreements requiring compliance with Code of Conduct
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: UN Global Compact
Certifications: ISO 13485, MDR 2017/745, MDSAP
Sustainable Products & Innovation
- Sedaconda ACD (designed for efficient anesthetic use and reduced environmental impact)
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Sustainability
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2024
Environmental Metrics
ESG Focus Areas
- Sustainability